Mayne Pharma hit with shareholder class action over US antitrust probe

Class Actions 2021-08-03 11:11 am By Christine Caulfield | Melbourne

Please login to bookmark

Generic drug maker Mayne Pharma Group has been hit with a shareholder class action over disclosures in relation to price-fixing allegations by US authorities.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au